UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

LABS score- a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

BMC cancer, 2024-03, Vol.24 (1), p.281-281, Article 281

2024

Volltextzugriff (PDF)

Nineteen-year, real-world experience of first-line combination chemotherapy in patients with metastatic colorectal cancer: a propensity score analysis from southern Thailand

Journal of international medical research, 2023-08, Vol.51 (8), p.3000605231193583-3000605231193583

2023

Volltextzugriff (PDF)

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

Journal of clinical oncology, 2011-07, Vol.29 (21), p.2866-2875

2011

Volltextzugriff (PDF)

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

The New England journal of medicine, 2009-09, Vol.361 (10), p.947-957

2009

Volltextzugriff (PDF)

The Performance of a Survival Nomogram and Albumin-Bilirubin Grade as Prognostic Tools in Advanced Hepatocellular Carcinoma Treated with FOLFOX4

Journal of personalized medicine, 2024-04, Vol.14 (4), p.403

2024

Volltextzugriff (PDF)

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1059-1066

2011

Volltextzugriff (PDF)

Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis

BMC cancer, 2019-12, Vol.19 (1), p.1174-1174, Article 1174

2019

Volltextzugriff (PDF)

Comparing the Efficacy of Carboplatin plus 5-Fluorouracil, Cisplatin plus 5-Fluorouracil, and Best Supportive Care for Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Analysis from a Tertiary Hospital in Southern Thailand

Journal of clinical medicine, 2024-03, Vol.13 (6), p.1735

2024

Volltextzugriff (PDF)

Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer

Clinical Medicine Insights. Oncology, 2022, Vol.16, p.11795549221092747-11795549221092747

2022

Volltextzugriff (PDF)

Metastatic Primary Testicular Neuroendocrine Carcinoma Associated with Somatic Malignant Transformation of Teratoma: A Rare Case Report

Case reports in oncology, 2022-01, Vol.15 (1), p.191-198

2022

Volltextzugriff (PDF)

Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients

Journal of cancer research and clinical oncology, 2016-04, Vol.142 (4), p.749-756

2016

Volltextzugriff (PDF)

Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma

Journal of cancer research and clinical oncology, 2005-02, Vol.131 (2), p.111-119

2005

Volltextzugriff (PDF)

Su1276 CARBOPLATIN PLUS 5-FLUOROURACIL AS AN ALTERNATIVE FIRST-LINE PALLIATIVE TREATMENT FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: 11-YEAR EXPERIENCE FROM A TERTIARY HOSPITAL IN SOUTHERN THAILAND

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-721-S-721

2024

Volltextzugriff (PDF)

The prevalence and assessment of ErbB2‐positive breast cancer in Asia

Cancer, 2010-12, Vol.116 (23), p.5348-5357

2010

Volltextzugriff (PDF)

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

The Lancet (British edition), 2021-08, Vol.398 (10302), p.759-771

2021

Volltextzugriff (PDF)

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Nature medicine, 2023-08, Vol.29 (8), p.2133-2141

2023

Volltextzugriff (PDF)

Prevention of cisplatin nephrotoxicity (CN) in head and neck cancer patients receiving concurrent chemoradiation (CCRT) by adding oral rehydration solution (ORS) to short hydration regimen: A randomized open-label controlled trial

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18560-e18560

2020

Volltextzugriff (PDF)

Three-dimensional (3D) telomeric architecture of esophageal squamous cell carcinoma

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15048-e15048

2014

Volltextzugriff (PDF)

Cervical cancer screening in incarcerated women: An experience from the first cervical cancer screening campaign in a southern Thailand correctional facility

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6572-6572

2019

Volltextzugriff (PDF)

Copy number gains of chromosome 17 identified by dual in situ hybridization in non-small cell lung cancer tissue correlate with overexpression of c-Myc

Translational cancer research, 2022-05, Vol.11 (5), p.1033-1044

2022

Volltextzugriff (PDF)

Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature

The American journal of case reports, 2024-06, Vol.25, p.e944002-e944002

2024

Volltextzugriff (PDF)

Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1063-1063

2023

Volltextzugriff (PDF)

Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer

Journal of gastrointestinal cancer, 2020-09, Vol.51 (3), p.947-951

2020

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Oncology
(26)
Humans
(25)
Female
(20)
Male
(19)
Aged
(16)
Middle Aged
(16)
Chemotherapy
(13)
Adult
(12)
Tumors
(11)
Patients
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Metastasis
(9)
Aged, 80 And Over
(8)
Cancer Therapies
(8)
Cancer
(7)
Treatment Outcome
(7)
Biological And Medical Sciences
(6)
Immunohistochemistry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

LABS score- a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

Nineteen-year, real-world experience of first-line combination chemotherapy in patients with metastatic colorectal cancer: a propensity score analysis from southern Thailand

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

The Performance of a Survival Nomogram and Albumin-Bilirubin Grade as Prognostic Tools in Advanced Hepatocellular Carcinoma Treated with FOLFOX4

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis

Comparing the Efficacy of Carboplatin plus 5-Fluorouracil, Cisplatin plus 5-Fluorouracil, and Best Supportive Care for Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Analysis from a Tertiary Hospital in Southern Thailand

Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer

Metastatic Primary Testicular Neuroendocrine Carcinoma Associated with Somatic Malignant Transformation of Teratoma: A Rare Case Report

Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients

Phase 2 Study of Erlotinib in Combination with Linsitinib (OSI-906) or Placebo in Chemotherapy-naive Patients with Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations

Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma

Su1276 CARBOPLATIN PLUS 5-FLUOROURACIL AS AN ALTERNATIVE FIRST-LINE PALLIATIVE TREATMENT FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: 11-YEAR EXPERIENCE FROM A TERTIARY HOSPITAL IN SOUTHERN THAILAND

The prevalence and assessment of ErbB2‐positive breast cancer in Asia

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Prevention of cisplatin nephrotoxicity (CN) in head and neck cancer patients receiving concurrent chemoradiation (CCRT) by adding oral rehydration solution (ORS) to short hydration regimen: A randomized open-label controlled trial

Three-dimensional (3D) telomeric architecture of esophageal squamous cell carcinoma

Cervical cancer screening in incarcerated women: An experience from the first cervical cancer screening campaign in a southern Thailand correctional facility

Copy number gains of chromosome 17 identified by dual in situ hybridization in non-small cell lung cancer tissue correlate with overexpression of c-Myc

Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature

Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial

Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer

Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Suchergebnisse filtern